Save this technology
close
Save to Existing Project
Save to a New Project
Seeking a Phase III End Oncology Focused Product with Improved Results Against Todays Existing Treatment of Choice
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
New cancer treatment modality with clearly improved treatment results for today´s treatment of choice...
Contact Leena Rinne
Participants
You
Email me a copy of this message

-new cancer treatment modality with clearly improved treatment results for today´s treatment of choice


-areas where clear unmet medical needs exists

Type of Business Relationship Sought

No active co-funding or co-development role for Takeda in Nordics

FEATURED
Last Updated Sep 2014
Technology Type
Phase of Development CLINICAL TRIALS
CORPORATION

Opportunity Contact